Vinva Investment Management Ltd
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1968109
SYDNEY, C3
Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,076,303
+$944,923 QoQ
Shares Held
32,126
+91.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vinva Investment Management Ltd holds $66,411,479 across 13 Biotechnology names. HALO ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
300,405 | $28,274,118 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
36,601 | $12,110,172 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,862 | $11,482,975 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,531 | $4,255,972 | |
| 5 | EXEL |
Exelixis, Inc.
|
49,204 | $2,110,359 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
11,142 | $2,106,395 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
This page
|
32,126 | $2,076,303 | |
| 8 | ASND |
Ascendis Pharma A/S
|
5,694 | $1,302,388 |
All Filings in HALO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,076,303 | 32,126 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,131,380 | 16,811 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $772,123 | 10,528 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $286,734 | 5,512 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $268,767 | 4,212 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $138,314 | 2,893 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $212,895 | 4,066 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||